These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17052143)

  • 1. TMC114 approved for resistant patients.
    AIDS Patient Care STDS; 2006 Oct; 20(10):731. PubMed ID: 17052143
    [No Abstract]   [Full Text] [Related]  

  • 2. Darunavir (TMC114) approved by the FDA.
    AIDS Alert; 2007 Feb; 22(2):22-3. PubMed ID: 17763549
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 4. Darunavir now approved for use in treatment-naive patients.
    Sax PE
    AIDS Clin Care; 2008 Dec; 20(12):102. PubMed ID: 19271337
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA clears HIV drug for patients with resistant virus.
    AIDS Read; 2006 Aug; 16(8):392. PubMed ID: 16933372
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves darunavir.
    AIDS Patient Care STDS; 2008 Dec; 22(12):1021-2. PubMed ID: 19097261
    [No Abstract]   [Full Text] [Related]  

  • 7. Different evidence of key amprenavir resistance mutations on the efficacy of darunavir.
    Di Biagio A; Rosso R; Bruzzone B; Cenderello G; Dentone C; Mularoni A; Ferrea G; Icardi G; Viscoli C
    AIDS; 2008 Jan; 22(3):437-8. PubMed ID: 18195574
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2.
    Pozniak A; Opravil M; Beatty G; Hill A; de Béthune MP; Lefebvre E
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1275-80. PubMed ID: 18844462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval: darunavir.
    Sax PE
    AIDS Clin Care; 2006 Aug; 18(8):71. PubMed ID: 16906668
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. New 600 mg tablet strength for darunavir is approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):47. PubMed ID: 19253456
    [No Abstract]   [Full Text] [Related]  

  • 11. New HIV treatment.
    FDA Consum; 2006; 40(5):7. PubMed ID: 17326304
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.
    Poveda E; Blanco F; García-Gascó P; Alcolea A; Briz V; Soriano V
    AIDS; 2006 Jul; 20(11):1558-60. PubMed ID: 16847414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darunavir (Prezista) for HIV infection.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):74-5. PubMed ID: 16977286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.
    Boffito M; Miralles D; Hill A
    HIV Clin Trials; 2008; 9(6):418-27. PubMed ID: 19203907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 16. [Maintaining independence. New protease inhibitor receives drug approval recommendation].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():84-5. PubMed ID: 15373062
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.
    Katlama C; Esposito R; Gatell JM; Goffard JC; Grinsztejn B; Pozniak A; Rockstroh J; Stoehr A; Vetter N; Yeni P; Parys W; Vangeneugden T;
    AIDS; 2007 Feb; 21(4):395-402. PubMed ID: 17301557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials.
    Poveda E; Vispo E; Pattery T; de Mendoza C; Villacian J; Soriano V
    J Antimicrob Chemother; 2007 Dec; 60(6):1411-3. PubMed ID: 17911388
    [No Abstract]   [Full Text] [Related]  

  • 19. Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients.
    Delaugerre C; Mathez D; Peytavin G; Berthé H; Long K; Galperine T; de Truchis P
    AIDS; 2007 May; 21(9):1210-3. PubMed ID: 17502734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darunavir (TMC114): a new HIV-1 protease inhibitor.
    Molina JM; Hill A
    Expert Opin Pharmacother; 2007 Aug; 8(12):1951-64. PubMed ID: 17696796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.